Adsorption and transformation of selected human-used macrolide antibacterial agents with iron(III) and manganese(IV) oxides

被引:53
作者
Feitosa-Felizzola, Juliana [1 ]
Hanna, Khalil [2 ]
Chiron, Serge [1 ]
机构
[1] Aix Marseille Univ, Lab Chim Provence, CNRS, UMR 6264, F-13331 Marseille 3, France
[2] Univ Nancy 1, Lab Chim Phys & Microbiol Environm, CNRS, UMR 7564, F-54600 Villers Les Nancy, France
关键词
Macrolides; Oxy-hydroxides; Adsorption/transformation; Environmental fate; Surface reaction; WATER TREATMENT PLANTS; VETERINARY ANTIBIOTICS; CATALYZED DEGRADATION; MASS-SPECTROMETRY; NMR-SPECTROSCOPY; ERYTHROMYCIN-A; CLARITHROMYCIN; ROXITHROMYCIN; PHARMACEUTICALS; TRIMETHOPRIM;
D O I
10.1016/j.envpol.2008.11.048
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The adsorption/transformation of two members (clarithromycin and roxithromycin) of the macrolide (ML) antibacterial agents on the surface of three environmental subsurface sorbents (clay, iron(III) and manganese(IV) oxy-hydroxides) was investigated. The adsorption fitted well to the Freundlich model with a high sorption capacity. Adsorption probably occurred through a surface complexation mechanism and was accompanied by slow degradation of the selected MLs. Transformation proceeded through two parallel pathways: a major pathway was the hydrolysis of the cladinose sugar, and to a lesser extent the hydrolysis of the lactone ring. A minor pathway was the N-dealkylation of the amino sugar. This study indicates that Fe(III) and Mn(IV) oxy-hydroxides in aquatic sediments may play an important role in the natural attenuation of MLs. Such an attenuation route yields a range of intermediates that might retain some of their biological activity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1317 / 1322
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 1984, SURFACE CHEM SOILS
[2]   Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation [J].
Besse, Jean-Philippe ;
Garric, Jeanne .
TOXICOLOGY LETTERS, 2008, 176 (02) :104-123
[3]   A comparative study of approaches used to improve solubility of roxithromycin [J].
Biradar, Shailesh V. ;
Patil, Arpana R. ;
Sudarsan, Guditi V. ;
Pokharkar, Varsha B. .
POWDER TECHNOLOGY, 2006, 169 (01) :22-32
[4]   Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy [J].
Calamari, D ;
Zuccato, E ;
Castiglioni, S ;
Bagnati, R ;
Fanelli, R .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2003, 37 (07) :1241-1248
[5]  
DEVINEAU K, 2007, CRP1ENG051
[6]   Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking [J].
Gao, Yan ;
Cui, Fu-de ;
Guan, Ying ;
Yang, Lei ;
Wang, Yong-sheng ;
Zhang, Li-na .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 318 (1-2) :62-69
[7]   A COMPARATIVE NMR-STUDY BETWEEN THE MACROLIDE ANTIBIOTIC ROXITHROMYCIN AND ERYTHROMYCIN-A WITH DIFFERENT BIOLOGICAL PROPERTIES [J].
GHARBIBENAROUS, J ;
DELAFORGE, M ;
JANKOWSKI, CK ;
GIRAULT, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (03) :1117-1125
[8]   Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the ebro river basin (northeast spain) [J].
Gros, Meritxell ;
Petrovic, Mira ;
Barcelo, Damia .
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2007, 26 (08) :1553-1562
[9]  
Hamdan II, 2003, PHARMAZIE, V58, P223
[10]   Toxic and genotoxic evaluation of six antibiotics on non-target organisms [J].
Isidori, M ;
Lavorgna, M ;
Nardelli, A ;
Pascarella, L ;
Parrella, A .
SCIENCE OF THE TOTAL ENVIRONMENT, 2005, 346 (1-3) :87-98